Tesofensine
Tesofensine is an oral tablet first developed for Parkinson's and Alzheimer's disease that has shown weight loss effects.
We have not published an audit on Tesofensine. Everything below is reference material, not our own reading of the literature, treat it as a starting point for questions, not as a grade.
How it is thought to work
It works in the brain by blocking the reuptake of three signaling chemicals: dopamine, norepinephrine, and serotonin, leading to lower appetite and increased resting energy use. [Source: Peptide Dosing Protocols]
Tesofensine works by blocking the brain's recycling of dopamine, norepinephrine, and serotonin, so more of these signals stay active, reducing appetite and slightly increasing the body's resting calorie burn.
Reported side effects
The most commonly reported side effects are dry mouth, nausea, constipation, insomnia, dizziness, and an increased heart rate, with about 20% of participants in the 0.5 mg trial arm stopping due to adverse events.
Who should avoid it
People with heart disease, uncontrolled high blood pressure, psychiatric conditions, or those taking MAO inhibitors, SSRIs, SNRIs, or strong CYP3A4 inhibitors should avoid it, as should pregnant or breastfeeding individuals and anyone under 18.
What gets monitored
Resting heart rate and blood pressure at baseline and regular intervals; body weight and waist circumference; mood, sleep, and anxiety screening, especially in the first few weeks; signs of fluid changes; routine labs (glucose, lipids, electrolytes). [Source: Peptide Dosing Protocols]